海新能科(300072) - 2025 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2025 reached ¥958,387,625.42, representing a year-over-year increase of 63.82%[5] - Net profit attributable to shareholders was ¥93,332,441.42, with a significant improvement compared to the previous year's loss[5] - The net profit after deducting non-recurring gains and losses was ¥46,647,052.48, a substantial recovery from a loss of ¥25,305,630.88 in the same period last year, marking a 95.91% increase[5] - Basic and diluted earnings per share for the period were both ¥0.0397, compared to ¥0.0247 for the same period last year[5] - The company achieved profitability in its business segment by leveraging the rising market opportunities for hydrocarbon-based biodiesel, successfully fulfilling long-term sales contracts with non-EU customers and exceeding delivery expectations[22] - Net profit for the current period was ¥2,083,081.18, a significant recovery from a net loss of ¥703,316,269.14 in the previous period[30] - Basic and diluted earnings per share were 0.0247, compared to -0.2695 in the prior period[31] Assets and Liabilities - Total assets at the end of the reporting period were ¥8,433,824,973.59, down 13.18% from the previous year[5] - Total assets decreased to ¥8,433,824,973.59 from ¥9,713,921,182.83, a decline of approximately 13.2%[27] - Current liabilities totaled ¥2,324,587,039.82, down from ¥3,383,962,231.16, representing a decrease of about 31.2%[27] - The total owner's equity amounted to ¥5,920,120,435.00, a slight decrease from ¥5,926,240,753.37[27] Cash Flow - The company's cash flow from operating activities showed a negative net amount of ¥98,448,911.13, reflecting a decline of 147.72% year-to-date[5] - Cash flow from operating activities generated a net outflow of -98,448,911.13, down from a net inflow of 206,317,488.40 in the previous year[33] - Cash inflow from investment activities was 1,292,666,815.89, a substantial increase from 72,918,894.02 in the prior period[33] - Net cash flow from financing activities showed a significant outflow of -1,189,441,966.57, compared to a net inflow of 36,860,784.23 in the previous year[33] - The total cash and cash equivalents at the end of the period were 577,770,407.01, down from 624,441,877.42 at the end of the previous period[33] - The company received cash from borrowings amounting to 373,000,000.00, an increase from 205,260,000.00 in the prior period[33] - Cash received from other investment activities was 1,232,248,748.01, a significant rise from 23,000,000.00 in the previous year[33] Operational Efficiency - The company reported a significant decrease in other receivables by 86.56% due to repayments received from debtors[9] - The company’s operational management level has steadily improved, focusing on quality control, supplier management, and catalyst solutions[22] - The company’s domestic catalytic purification business is committed to optimizing product structure and ensuring stable business development[22] - The company reported a decrease in research and development expenses to ¥78,848,723.16 from ¥91,987,544.93, indicating a reduction of about 14.3%[30] Financial Management - Financial expenses decreased by 39.14% to ¥60,892,346.78 compared to the same period last year, primarily due to reduced financing lease interest from Shandong Sanju Bioenergy Co., Ltd.[12] - The company reported a significant reduction in financial expenses, which fell to ¥60,892,346.78 from ¥100,059,984.53, a decrease of about 39.0%[30] - Credit impairment losses showed a significant improvement, decreasing by 170.72% to ¥135,994,777.55, as the company received repayments from debtors, reversing previous impairment losses.[12] Market and Growth Strategy - The company plans to continue expanding its market presence and developing new technologies to enhance its competitive edge[5] - The company signed long-term supply agreements with multiple core suppliers, enhancing its raw material supply chain security[22] - The company received approval from the Ministry of Commerce and other four ministries for the pilot export of bio-jet fuel, allowing it to independently apply for export permits, which improves production scheduling and capacity utilization[22] - The company has signed bio-jet fuel orders with overseas customers, indicating a full production schedule for the fourth quarter[22] Tax and Compliance - Cash received from tax refunds decreased by 38.15% to ¥383,542.09, mainly due to a reduction in export tax rebates.[14] - Cash paid for various taxes dropped by 81.74% to ¥27,306,523.91, primarily due to a decrease in value-added tax payments.[15]